Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01492764 · ClinicalTrials.gov registry record

Ablation of Ventricular Fibrillation by Accurate Targeting of Arrhythmogenic Regions (AVATAR)

A clinical trial, sponsored by University of California, San Diego.

Completed
Registry status
2
Enrollment target

NCT01492764: Completed study, sponsored by University of California, San Diego.

NCT01492764 is a clinical trial that has completed, run by University of California, San Diego. The registered enrollment target is 2 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01492764 has completed, sponsored by University of California, San Diego.

COMPLETED
Registry status
2 participants
Enrollment target

Study Summary

This study will test the hypothesis that many human heart rhythm disorders are caused by small localized sources, where brief ablation may successfully eliminate the heart rhythm disorder.

Primary Outcome

Using careful clinical monitoring, we will compare the burden of VT/VF after ablation (including FIRM) to the burden preceding ablation.

Trial Details

FieldValue
Enrollment Target 2 participants
Start Date 2011-06
Est. Completion 2014-08
University of California, San Diego

775 total trials

What the finished NCT01492764 record still lists

NCT01492764 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 2 participants, a relatively small participant target.

The record links to 0 conditions, and to 0 interventions.

NCT01492764 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT01492764 about?

NCT01492764 is a clinical study titled "Ablation of Ventricular Fibrillation by Accurate Targeting of Arrhythmogenic Regions (AVATAR)". This study will test the hypothesis that many human heart rhythm disorders are caused by small localized sources, where brief ablation may successfully eliminate the heart rhythm disorder.

What is the current status of trial NCT01492764?

This trial is currently completed. The enrollment target is 2 participants. The study started on 2011-06. Estimated completion is 2014-08.

Who is sponsoring clinical trial NCT01492764?

This trial is sponsored by University of California, San Diego, which has 775 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01492764, the US trial registry maintained by the National Library of Medicine. NCT01492764 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.